Rafferty Asset Management’s C4 Therapeutics CCCC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-143,855
| Closed | -$820K | – | 1146 |
|
|
2024
Q3 | $820K | Sell |
143,855
-41,883
| -23% | -$239K | ﹤0.01% | 838 |
|
|
2024
Q2 | $858K | Sell |
185,738
-647,943
| -78% | -$2.99M | ﹤0.01% | 848 |
|
|
2024
Q1 | $6.81M | Buy |
+833,681
| New | +$6.81M | 0.03% | 387 |
|
|
2023
Q1 | – | Sell |
-177,858
| Closed | -$1.05M | – | 1148 |
|
|
2022
Q4 | $1.05M | Buy |
177,858
+65,208
| +58% | +$385K | 0.01% | 741 |
|
|
2022
Q3 | $988K | Buy |
+112,650
| New | +$988K | 0.01% | 684 |
|
|
2022
Q2 | – | Sell |
-135,392
| Closed | -$3.29M | – | 1150 |
|
|
2022
Q1 | $3.29M | Buy |
135,392
+43,385
| +47% | +$1.05M | 0.02% | 487 |
|
|
2021
Q4 | $2.96M | Buy |
92,007
+32,956
| +56% | +$1.06M | 0.02% | 541 |
|
|
2021
Q3 | $2.64M | Buy |
59,051
+10,218
| +21% | +$456K | 0.02% | 547 |
|
|
2021
Q2 | $1.85M | Buy |
48,833
+1,927
| +4% | +$72.9K | 0.01% | 707 |
|
|
2021
Q1 | $1.74M | Buy |
+46,906
| New | +$1.74M | 0.01% | 661 |
|